Oklahoma Senate Bill SB150

Oklahoma 2022 Regular Session

• Introduced: 2/1/21
• Refer: 2/2/21

Caption

Stem cell research; removing certain information collection and reporting duties of the State Department of Health. Effective date.

Impact

This bill will remove certain reporting responsibilities from the State Department of Health concerning stem cell research activities. By lightening the bureaucratic load on the department, supporters argue that this change will enable more efficient research processes, potentially encouraging greater investments and advancements in stem cell therapies. However, there are concerns regarding the implications of removing these reporting duties, as it raises questions about oversight and the tracking of research practices.

Summary

Senate Bill 150, introduced by Senator Rogers, focuses on stem cell research in the state of Oklahoma. The bill proposes amendments to 63 O.S. 2011, Section 1-270.2, specifically aimed at streamlining the regulation of stem cell research activities. It clarifies definitions related to human embryos and allows research on adult stem cells and stem cells obtained from umbilical cord blood and amniotic fluid, provided it adheres to ethical and safety standards. The intent behind these amendments is to foster advancements in stem cell technologies while maintaining compliance with existing federal laws.

Contention

Notable discussions surrounding SB150 involve differing opinions from various stakeholders. Proponents argue that easing restrictions will enhance research efforts in a field that holds significant promise for medical breakthroughs. Conversely, opponents fear that reduced oversight could facilitate unethical practices or lead to the exploitation of stem cell research under less stringent guidelines. This tension reflects a broader debate about the balance between fostering innovation in medical research and ensuring ethical standards are upheld.